Integrity of the growth hormone/insulin-like growth factor system is maintained in patients with chronic fatigue syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 4, 2000, Pages 1433-1439

  Cleare, Anthony J ^a,b   Sookdeo, Samantha S ^a   Jones, Jennifer ^a   O'Keane, Veronica ^c   Miell, John P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; INSULIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STRESS;

ADULT; EXERCISE TEST; FATIGUE SYNDROME, CHRONIC; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE;

EID: 0034457036     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.4.1433     Document Type: Article

References (53)

1. Chronic fatigue syndrome
2. Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome
3. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome
4. Increased brain serotonin function in men with chronic fatigue syndrome
5. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome
6. Increased prolactin response to buspirone in chronic fatigue syndrome
7. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome
8. Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome
9. Low-dose hydrocortisone in chronic fatigue syndrome: A randomised crossover trial
10. Low-dose hydrocortisone treatment of chronic fatigue syndrome: Results of a placebo controlled study of its efficacy and safety
11. Quality of life, body composition and muscle strength in adult growth hormone deficiency: The influence of growth hormone replacement therapy for up to 3 years
12. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency
13. Decreased psychological well-being in adult patients with growth hormone deficiency
14. Can the use of growth hormone reduce the postoperative fatigue syndrome?
15. Chronic fatigue and minor psychiatric morbidity after viral meningitis: A controlled study
16. Selective disruption of growth hormone transcription machinery by viral infection
17. Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome
18. Insulin-like growth factor-1 (somato-medin C) levels in chronic fatigue syndrome and fibromyalgia
19. Somatomedin C (insulin-like growth factor I) levels in patients with chronic fatigue syndrome
20. Chronic fatigue syndrome. A practical guide to assessment and management
21. The chronic fatigue syndrome: A comprehensive approach to its definition and study
22. Chronic fatigue syndrome: Guidelines for research
23. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia
24. Development of a fatigue scale
25. A population based study of fatigue and psychological distress
26. The MOS Short-form General Health Survey: Reliability and validity in a patient population
27. Somatic discomforts among depressed women
28. Variability in the urinary excretion of growth hormone in children: A comparison with other urinary proteins
29. Secretion of growth hormone in patients with chronic fatigue syndrome
30. Functional somatic syndromes: One or many?
31. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome
32. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome
33. The effect of growth hormone treatment in patients with chronic fatigue syndrome: A preliminary study
34. Defective dexamethasone induced growth hormone release in chronic fatigue syndrome; evidence for glucocorticoid receptor resistance and lack of plasticity?
35. Insulin-like growth factors and their binding proteins: Biological actions
36. Insulin-like growth factor binding protein-1: Recent findings and new directions
37. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart
38. Insulin-like growth factor binding proteins as glucoregulators
39. A review of GHRH stimulation test in psychiatry
40. Insulin-induced hypoglycaemic response and release of growth hormone in depressed patients and healthy controls
41. Psychoneuroendocrinology of depression. Growth hormone
42. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopami nergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers
43. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers
44. Suppressive effects of glucocorticoids on arginine-induced growth hormone release in normal subjects
45. Effects of corticosteroids on serum growth hormone
46. Responses of plasma growth hormone and corticosteroids to insulin and arginine with or without prior administration of dexamethasone
47. Human growth hormone: Clinical measurement, response to hypoglycaemia and suppression by corticosteroids
48. Effect of human growth hormone releasing hormone on GH secretion in Cushing's syndrome and non-endocrine disease patients treated with glucocorticoids
49. Growth hormone secretion: The role of glucocorticoids